Pulmonary Embolism
Pulmonary Embolism
A pulmonary embolism is a blockage of an artery in the lungs caused by a blood clot. Symptoms include chest pain or discomfort, shortness of breath, coughing up blood, and lightheadedness. Diagnosis involves computed tomography pulmonary angiogram (CTPA), ventilation-perfusion scan, and echocardiogram tests.
Show Medications for Pulmonary Embolism
18/05/2026
Updated: 12/06/2026
Pulmonary Embolism
What is a Pulmonary Embolism?
A pulmonary embolism (PE) occurs when a blood clot, called a thrombus, breaks loose from its original location and travels through the bloodstream to the lungs. This can block one or more of the arteries in the lungs, which can be life-threatening if not treated promptly.
Key Symptoms
The symptoms of a pulmonary embolism can vary from person to person, but common signs include:
- Chest pain or discomfort that worsens with deep breathing or coughing
- Shortness of breath (dyspnea) that may be sudden and severe
- Coughing up blood (hemoptysis)
- Lightheadedness or dizziness, which can indicate a drop in blood pressure
Diagnostic Tests
To diagnose a pulmonary embolism, your doctor may order one or more of the following tests:
- Computed Tomography Pulmonary Angiogram (CTPA): an imaging test that uses X-rays and contrast dye to visualize the blood vessels in the lungs
- Ventilation-Perfusion Scan: a nuclear medicine test that measures airflow and blood flow to the lungs
- Echocardiogram: an ultrasound test that evaluates heart function and detects any blockages or clots in the heart's chambers or valves
Treatment of Pulmonary Embolism
Gold Standard Treatment: Thrombolysis (e.g., alteplase)
Thrombolysis is the gold standard treatment for pulmonary embolism, particularly in patients with hemodynamic instability or severe symptoms. This treatment involves the administration of a thrombolytic agent, such as alteplase, which works by dissolving the blood clot that has formed in the lungs. Alteplase is a recombinant tissue plasminogen activator (tPA) that activates the fibrinolytic system, leading to the breakdown of fibrin clots. This process restores blood flow to the affected area and reduces the risk of further complications.Alternatives to Thrombolysis
Anticoagulation with Heparin or Low Molecular Weight Heparin:
Anticoagulants, such as heparin or low molecular weight heparin, are used to prevent the formation of new blood clots and promote the dissolution of existing clots. These medications work by inhibiting the coagulation cascade, thereby reducing the risk of further thromboembolic events.Thrombin Inhibitors (e.g., dabigatran):
Thrombin inhibitors, such as dabigatran, are direct oral anticoagulants that work by inhibiting the activity of thrombin. This leads to a reduction in blood clot formation and an increase in the breakdown of existing clots.Surgery (Embolectomy):
In cases where thrombolysis is contraindicated or has failed, surgery may be necessary to remove the blood clot. Embolectomy involves the surgical removal of the clot from the pulmonary artery, restoring normal blood flow to the lungs.
Pulmonary Embolism: Causes and Risk Factors
Introduction
Pulmonary embolism is a serious medical condition that occurs when a blood clot (thrombus) breaks loose from its site of formation, travels through the bloodstream, and lodges in one or more pulmonary arteries. This can lead to blockage of blood flow to the lungs, resulting in tissue death and potentially life-threatening complications.Risk Factors
The following factors increase an individual's risk of developing a pulmonary embolism:- Prolonged bed rest or immobility: Prolonged periods of inactivity can lead to blood stasis, increasing the likelihood of clot formation.
- Recent surgery or trauma: Surgery and trauma can cause damage to blood vessels, leading to increased risk of thrombosis.
- Family history of thrombophilia: Individuals with a family history of blood clotting disorders are at higher risk of developing pulmonary embolism.
- Obesity: Excess weight can lead to increased pressure on the veins, increasing the risk of clot formation.